16 results
8-K
EX-99.2
RPTX
Repare Therapeutics Inc
7 May 24
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
4:10pm
comparable: Entry Hg Gender and age Prior lines and therapies ECOG Histologies and DOT Differences in anemia rates likely a result of the updated dosing
DEF 14A
RPTX
Repare Therapeutics Inc
1 Apr 21
Definitive proxy
7:36am
and perspective on the board, the committee also takes into account gender, sexual preference, disability, age, ethnicity, business experience, functional … and corporate governance committee typically considers diversity (including gender, sexual preference, disability, age, ethnicity, business experience
8-K
EX-3.2
tzrtku36a
23 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:36pm
S-1/A
EX-3.5
jk2 su9hfz2w2y
15 Jun 20
IPO registration (amended)
6:18am
S-1/A
EX-10.14
7mbk0
15 Jun 20
IPO registration (amended)
6:18am
S-1
EX-10.1
fhbycg28 7q1e4s
29 May 20
IPO registration
5:26pm
S-1
EX-4.2
gbaere6e8i3v8qiy 6g
29 May 20
IPO registration
5:26pm
S-1
EX-10.15
i9at rx8qu
29 May 20
IPO registration
5:26pm
S-1
EX-10.14
r6e0icw 97g
29 May 20
IPO registration
5:26pm
DRS
EX-4.2
kto6o01 67mfpsz
6 Apr 20
Draft registration statement
12:00am
DRS
EX-10.1
o5h 8am68
6 Apr 20
Draft registration statement
12:00am
DRS
EX-10.14
6j7f80wd6l4
6 Apr 20
Draft registration statement
12:00am
- Prev
- 1
- Next